Comparison
46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197 vs 3mc Syndrome 2 C0796279
Clinical comparison between 46 XX Disorder OF Sex Development Induced BY Maternal Derived Androgen and 3mc Syndrome 2 for differential diagnosis and treatment planning.
46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197
A condition where androgens from the pregnant person cross to the fetus, causing atypical genital development in an XX baby. It ranges from mild to severe. Specialists guide hormone and surgical management.
3mc Syndrome 2 C0796279
A rare genetic condition similar to other 3MC types, affecting multiple systems with facial, developmental, and growth manifestations. Treatment focuses on symptom management.
6 comparison axes
Onset
46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197
0-0
3mc Syndrome 2 C0796279
0-0
Onset patterns differ
Severity
46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197
severe
3mc Syndrome 2 C0796279
moderate
Different severity levels
Chronic
46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197
Chronic
3mc Syndrome 2 C0796279
Chronic
Differing course
Communicable
46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197
No
3mc Syndrome 2 C0796279
No
Different transmission
Body System
46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197
reproductive
3mc Syndrome 2 C0796279
congenital
Same/different system
Category
46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197
endocrine
3mc Syndrome 2 C0796279
genetic
Different category
Bottom line
46-xx-disorder-of-sex-development-induced-by-maternal-derived-androgen-C5680197 and 3mc-syndrome-2-C0796279 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197 | 3mc Syndrome 2 C0796279 | Discriminating power |
|---|---|---|---|
| Genital development | Atypical genital development in an XX baby, ranging from mild to severe. | Not described as primarily caused by maternal androgen exposure. | High |
| Multisystem features | Supplied focus is reproductive and endocrine; other features are not established. | Facial, developmental, and growth manifestations may affect multiple systems. | High |
| Cause | Androgens from the pregnant person cross to the fetus. | Rare genetic condition similar to other 3MC types. | High |
When to favor each condition
Choose 46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197 when
XX infant with atypical genitalia and suspected maternal androgen exposure
This matches the described endocrine mechanism.
Moderate
Planning specialist hormone or surgical care
The source states specialists guide hormone and surgical management.
Moderate
Presentation centered on reproductive development without an established genetic syndrome
The supplied category is endocrine rather than genetic.
Low
Choose 3mc Syndrome 2 C0796279 when
Congenital facial, developmental, and growth features
These are the manifestations described for 3MC syndrome 2.
Moderate
Clinical suspicion of a genetic 3MC-type condition
The supplied category is genetic and care is symptom-focused.
Low
No evidence that maternal androgens explain the findings
The stated etiology differs from maternal-androgen DSD.
Moderate
How key tests differ
| Test | 46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197 | 3mc Syndrome 2 C0796279 | Interpretation |
|---|---|---|---|
| Chromosomal sex assessment | The named condition specifies 46,XX; confirmation is clinical. | Expected karyotype is not established by this source. | A chromosomal result supports classification but is not a complete diagnosis. |
| Androgen evaluation | May explore maternal-derived androgen exposure; cutoffs are not supplied. | Not identified as the defining test here. | Abnormal hormone results are findings requiring specialist interpretation. |
| Genetic testing | Not established as necessary from the endocrine description alone. | May support diagnosis when a genetic 3MC condition is suspected. | Specific genes and results are not provided and should not be assumed. |
Prognosis comparison
46 Xx Disorder Of Sex Development Induced By Maternal Derived Androgen C5680197
- Outcome
- Long-term outcome is not established; severity may range from mild to severe.
- Factors
- Degree of androgen effect and specialist care may matter, but evidence here is limited.
3mc Syndrome 2 C0796279
- Outcome
- The course is chronic and described as moderate, with symptom-focused management.
- Factors
- Extent of facial, developmental, and growth manifestations; exact prognosis is not established.
Time frame: Both are early-onset and chronic; precise timelines are not supplied.
Etiology, severity, affected systems, and access to appropriate specialist care.
Complications comparison
| Complication | Presentation |
|---|---|
| Reproductive concerns | Atypical genital development may be mild to severe. Not the core feature in the supplied description. Fertility and surgical outcomes are not established here. |
| Growth and development | Broader developmental effects are not established by the source. Developmental and growth manifestations may occur. Severity is described as moderate, but individual course varies. |
| Ongoing specialist care | Endocrine and surgical specialists may be involved. Care focuses on managing symptoms across affected systems. Complication rates and long-term burdens are not quantified. |
Patient education highlights
- HighDifferent conditions
One is maternal-androgen-related 46,XX DSD; the other is rare genetic 3MC syndrome 2.
- HighSpecialist diagnosis
Physical findings and tests need clinician interpretation; do not self-diagnose from this comparison.
- MediumIndividualized care
DSD care may involve hormones or surgery, while 3MC care is symptom-focused; doses are not specified.